Published by Genetic Engineering & Biotechnology News, this article draws on insights from Bilal Ozdoganoglu, one of our Associate Senior Scientists.
The article explores our continuous bioprocessing platform for gene therapies, which combines perfusion technology and multi-column chromatography to help address challenges around manufacturing yield, productivity and scale.
The work aims to provide developers with an alternative to traditional batch processing and support the manufacture of therapies for larger patient populations.
